Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulinum Toxin to Avoid Component Separation in Midline Large Hernias

NCT04131348 is registered in ClinicalTrials.gov with Hospital Universitario La Fe as lead sponsor.

NCT NCT04131348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04131348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulinum Toxin to Avoid Component Separation in Midline Large Hernias
Lead sponsor
Hospital Universitario La Fe
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2016
Completion date
October 1, 2019
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

botulinum toxin type a, component separation, large midline hernia, rives repair